Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CRISPR-Based Therapeutics Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Genome Editing
1.2.3 Genetic Engineering
1.2.4 gRNA Database/Gene Librar
1.2.5 CRISPR Plasmid
1.2.6 Human Stem Cells
1.2.7 Genetically Modified Organisms/Crops
1.2.8 Cell Line Engineering
1.3 Market by Application
1.3.1 Global CRISPR-Based Therapeutics Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Biotechnology Companies
1.3.3 Pharmaceutical Companies
1.3.4 Academic Institutes
1.3.5 Research and Development Institutes
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global CRISPR-Based Therapeutics Market Perspective (2018-2033)
2.2 CRISPR-Based Therapeutics Growth Trends by Region
2.2.1 Global CRISPR-Based Therapeutics Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 CRISPR-Based Therapeutics Historic Market Size by Region (2018-2023)
2.2.3 CRISPR-Based Therapeutics Forecasted Market Size by Region (2024-2033)
2.3 CRISPR-Based Therapeutics Market Dynamics
2.3.1 CRISPR-Based Therapeutics Industry Trends
2.3.2 CRISPR-Based Therapeutics Market Drivers
2.3.3 CRISPR-Based Therapeutics Market Challenges
2.3.4 CRISPR-Based Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CRISPR-Based Therapeutics Players by Revenue
3.1.1 Global Top CRISPR-Based Therapeutics Players by Revenue (2018-2023)
3.1.2 Global CRISPR-Based Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global CRISPR-Based Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by CRISPR-Based Therapeutics Revenue
3.4 Global CRISPR-Based Therapeutics Market Concentration Ratio
3.4.1 Global CRISPR-Based Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CRISPR-Based Therapeutics Revenue in 2022
3.5 CRISPR-Based Therapeutics Key Players Head office and Area Served
3.6 Key Players CRISPR-Based Therapeutics Product Solution and Service
3.7 Date of Enter into CRISPR-Based Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 CRISPR-Based Therapeutics Breakdown Data by Type
4.1 Global CRISPR-Based Therapeutics Historic Market Size by Type (2018-2023)
4.2 Global CRISPR-Based Therapeutics Forecasted Market Size by Type (2024-2033)
5 CRISPR-Based Therapeutics Breakdown Data by Application
5.1 Global CRISPR-Based Therapeutics Historic Market Size by Application (2018-2023)
5.2 Global CRISPR-Based Therapeutics Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America CRISPR-Based Therapeutics Market Size (2018-2033)
6.2 North America CRISPR-Based Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America CRISPR-Based Therapeutics Market Size by Country (2018-2023)
6.4 North America CRISPR-Based Therapeutics Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CRISPR-Based Therapeutics Market Size (2018-2033)
7.2 Europe CRISPR-Based Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe CRISPR-Based Therapeutics Market Size by Country (2018-2023)
7.4 Europe CRISPR-Based Therapeutics Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CRISPR-Based Therapeutics Market Size (2018-2033)
8.2 Asia-Pacific CRISPR-Based Therapeutics Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific CRISPR-Based Therapeutics Market Size by Region (2018-2023)
8.4 Asia-Pacific CRISPR-Based Therapeutics Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CRISPR-Based Therapeutics Market Size (2018-2033)
9.2 Latin America CRISPR-Based Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America CRISPR-Based Therapeutics Market Size by Country (2018-2023)
9.4 Latin America CRISPR-Based Therapeutics Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CRISPR-Based Therapeutics Market Size (2018-2033)
10.2 Middle East & Africa CRISPR-Based Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa CRISPR-Based Therapeutics Market Size by Country (2018-2023)
10.4 Middle East & Africa CRISPR-Based Therapeutics Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Caribou Biosciences
11.1.1 Caribou Biosciences Company Detail
11.1.2 Caribou Biosciences Business Overview
11.1.3 Caribou Biosciences CRISPR-Based Therapeutics Introduction
11.1.4 Caribou Biosciences Revenue in CRISPR-Based Therapeutics Business (2018-2023)
11.1.5 Caribou Biosciences Recent Development
11.2 Addgene
11.2.1 Addgene Company Detail
11.2.2 Addgene Business Overview
11.2.3 Addgene CRISPR-Based Therapeutics Introduction
11.2.4 Addgene Revenue in CRISPR-Based Therapeutics Business (2018-2023)
11.2.5 Addgene Recent Development
11.3 CRISPR THERAPEUTICS
11.3.1 CRISPR THERAPEUTICS Company Detail
11.3.2 CRISPR THERAPEUTICS Business Overview
11.3.3 CRISPR THERAPEUTICS CRISPR-Based Therapeutics Introduction
11.3.4 CRISPR THERAPEUTICS Revenue in CRISPR-Based Therapeutics Business (2018-2023)
11.3.5 CRISPR THERAPEUTICS Recent Development
11.4 Merck KGaA
11.4.1 Merck KGaA Company Detail
11.4.2 Merck KGaA Business Overview
11.4.3 Merck KGaA CRISPR-Based Therapeutics Introduction
11.4.4 Merck KGaA Revenue in CRISPR-Based Therapeutics Business (2018-2023)
11.4.5 Merck KGaA Recent Development
11.5 Mirus Bio LLC
11.5.1 Mirus Bio LLC Company Detail
11.5.2 Mirus Bio LLC Business Overview
11.5.3 Mirus Bio LLC CRISPR-Based Therapeutics Introduction
11.5.4 Mirus Bio LLC Revenue in CRISPR-Based Therapeutics Business (2018-2023)
11.5.5 Mirus Bio LLC Recent Development
11.6 Editas Medicine
11.6.1 Editas Medicine Company Detail
11.6.2 Editas Medicine Business Overview
11.6.3 Editas Medicine CRISPR-Based Therapeutics Introduction
11.6.4 Editas Medicine Revenue in CRISPR-Based Therapeutics Business (2018-2023)
11.6.5 Editas Medicine Recent Development
11.7 Takara Bio USA
11.7.1 Takara Bio USA Company Detail
11.7.2 Takara Bio USA Business Overview
11.7.3 Takara Bio USA CRISPR-Based Therapeutics Introduction
11.7.4 Takara Bio USA Revenue in CRISPR-Based Therapeutics Business (2018-2023)
11.7.5 Takara Bio USA Recent Development
11.8 Thermo Fisher Scientific
11.8.1 Thermo Fisher Scientific Company Detail
11.8.2 Thermo Fisher Scientific Business Overview
11.8.3 Thermo Fisher Scientific CRISPR-Based Therapeutics Introduction
11.8.4 Thermo Fisher Scientific Revenue in CRISPR-Based Therapeutics Business (2018-2023)
11.8.5 Thermo Fisher Scientific Recent Development
11.9 Horizon Discovery Group
11.9.1 Horizon Discovery Group Company Detail
11.9.2 Horizon Discovery Group Business Overview
11.9.3 Horizon Discovery Group CRISPR-Based Therapeutics Introduction
11.9.4 Horizon Discovery Group Revenue in CRISPR-Based Therapeutics Business (2018-2023)
11.9.5 Horizon Discovery Group Recent Development
11.10 Intellia Therapeutics
11.10.1 Intellia Therapeutics Company Detail
11.10.2 Intellia Therapeutics Business Overview
11.10.3 Intellia Therapeutics CRISPR-Based Therapeutics Introduction
11.10.4 Intellia Therapeutics Revenue in CRISPR-Based Therapeutics Business (2018-2023)
11.10.5 Intellia Therapeutics Recent Development
11.11 GE Healthcare Dharmacon
11.11.1 GE Healthcare Dharmacon Company Detail
11.11.2 GE Healthcare Dharmacon Business Overview
11.11.3 GE Healthcare Dharmacon CRISPR-Based Therapeutics Introduction
11.11.4 GE Healthcare Dharmacon Revenue in CRISPR-Based Therapeutics Business (2018-2023)
11.11.5 GE Healthcare Dharmacon Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global CRISPR-Based Therapeutics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Genome Editing
Table 3. Key Players of Genetic Engineering
Table 4. Key Players of gRNA Database/Gene Librar
Table 5. Key Players of CRISPR Plasmid
Table 6. Key Players of Human Stem Cells
Table 7. Key Players of Genetically Modified Organisms/Crops
Table 8. Key Players of Cell Line Engineering
Table 9. Global CRISPR-Based Therapeutics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 10. Global CRISPR-Based Therapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 11. Global CRISPR-Based Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 12. Global CRISPR-Based Therapeutics Market Share by Region (2018-2023)
Table 13. Global CRISPR-Based Therapeutics Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 14. Global CRISPR-Based Therapeutics Market Share by Region (2024-2033)
Table 15. CRISPR-Based Therapeutics Market Trends
Table 16. CRISPR-Based Therapeutics Market Drivers
Table 17. CRISPR-Based Therapeutics Market Challenges
Table 18. CRISPR-Based Therapeutics Market Restraints
Table 19. Global CRISPR-Based Therapeutics Revenue by Players (2018-2023) & (US$ Million)
Table 20. Global CRISPR-Based Therapeutics Market Share by Players (2018-2023)
Table 21. Global Top CRISPR-Based Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR-Based Therapeutics as of 2022)
Table 22. Ranking of Global Top CRISPR-Based Therapeutics Companies by Revenue (US$ Million) in 2022
Table 23. Global 5 Largest Players Market Share by CRISPR-Based Therapeutics Revenue (CR5 and HHI) & (2018-2023)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players CRISPR-Based Therapeutics Product Solution and Service
Table 26. Date of Enter into CRISPR-Based Therapeutics Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global CRISPR-Based Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 29. Global CRISPR-Based Therapeutics Revenue Market Share by Type (2018-2023)
Table 30. Global CRISPR-Based Therapeutics Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 31. Global CRISPR-Based Therapeutics Revenue Market Share by Type (2024-2033)
Table 32. Global CRISPR-Based Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 33. Global CRISPR-Based Therapeutics Revenue Market Share by Application (2018-2023)
Table 34. Global CRISPR-Based Therapeutics Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 35. Global CRISPR-Based Therapeutics Revenue Market Share by Application (2024-2033)
Table 36. North America CRISPR-Based Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. North America CRISPR-Based Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America CRISPR-Based Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 39. Europe CRISPR-Based Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 40. Europe CRISPR-Based Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 41. Europe CRISPR-Based Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 42. Asia-Pacific CRISPR-Based Therapeutics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 43. Asia-Pacific CRISPR-Based Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 44. Asia-Pacific CRISPR-Based Therapeutics Market Size by Region (2024-2033) & (US$ Million)
Table 45. Latin America CRISPR-Based Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Latin America CRISPR-Based Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 47. Latin America CRISPR-Based Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 48. Middle East & Africa CRISPR-Based Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 49. Middle East & Africa CRISPR-Based Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 50. Middle East & Africa CRISPR-Based Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 51. Caribou Biosciences Company Detail
Table 52. Caribou Biosciences Business Overview
Table 53. Caribou Biosciences CRISPR-Based Therapeutics Product
Table 54. Caribou Biosciences Revenue in CRISPR-Based Therapeutics Business (2018-2023) & (US$ Million)
Table 55. Caribou Biosciences Recent Development
Table 56. Addgene Company Detail
Table 57. Addgene Business Overview
Table 58. Addgene CRISPR-Based Therapeutics Product
Table 59. Addgene Revenue in CRISPR-Based Therapeutics Business (2018-2023) & (US$ Million)
Table 60. Addgene Recent Development
Table 61. CRISPR THERAPEUTICS Company Detail
Table 62. CRISPR THERAPEUTICS Business Overview
Table 63. CRISPR THERAPEUTICS CRISPR-Based Therapeutics Product
Table 64. CRISPR THERAPEUTICS Revenue in CRISPR-Based Therapeutics Business (2018-2023) & (US$ Million)
Table 65. CRISPR THERAPEUTICS Recent Development
Table 66. Merck KGaA Company Detail
Table 67. Merck KGaA Business Overview
Table 68. Merck KGaA CRISPR-Based Therapeutics Product
Table 69. Merck KGaA Revenue in CRISPR-Based Therapeutics Business (2018-2023) & (US$ Million)
Table 70. Merck KGaA Recent Development
Table 71. Mirus Bio LLC Company Detail
Table 72. Mirus Bio LLC Business Overview
Table 73. Mirus Bio LLC CRISPR-Based Therapeutics Product
Table 74. Mirus Bio LLC Revenue in CRISPR-Based Therapeutics Business (2018-2023) & (US$ Million)
Table 75. Mirus Bio LLC Recent Development
Table 76. Editas Medicine Company Detail
Table 77. Editas Medicine Business Overview
Table 78. Editas Medicine CRISPR-Based Therapeutics Product
Table 79. Editas Medicine Revenue in CRISPR-Based Therapeutics Business (2018-2023) & (US$ Million)
Table 80. Editas Medicine Recent Development
Table 81. Takara Bio USA Company Detail
Table 82. Takara Bio USA Business Overview
Table 83. Takara Bio USA CRISPR-Based Therapeutics Product
Table 84. Takara Bio USA Revenue in CRISPR-Based Therapeutics Business (2018-2023) & (US$ Million)
Table 85. Takara Bio USA Recent Development
Table 86. Thermo Fisher Scientific Company Detail
Table 87. Thermo Fisher Scientific Business Overview
Table 88. Thermo Fisher Scientific CRISPR-Based Therapeutics Product
Table 89. Thermo Fisher Scientific Revenue in CRISPR-Based Therapeutics Business (2018-2023) & (US$ Million)
Table 90. Thermo Fisher Scientific Recent Development
Table 91. Horizon Discovery Group Company Detail
Table 92. Horizon Discovery Group Business Overview
Table 93. Horizon Discovery Group CRISPR-Based Therapeutics Product
Table 94. Horizon Discovery Group Revenue in CRISPR-Based Therapeutics Business (2018-2023) & (US$ Million)
Table 95. Horizon Discovery Group Recent Development
Table 96. Intellia Therapeutics Company Detail
Table 97. Intellia Therapeutics Business Overview
Table 98. Intellia Therapeutics CRISPR-Based Therapeutics Product
Table 99. Intellia Therapeutics Revenue in CRISPR-Based Therapeutics Business (2018-2023) & (US$ Million)
Table 100. Intellia Therapeutics Recent Development
Table 101. GE Healthcare Dharmacon Company Detail
Table 102. GE Healthcare Dharmacon Business Overview
Table 103. GE Healthcare Dharmacon CRISPR-Based Therapeutics Product
Table 104. GE Healthcare Dharmacon Revenue in CRISPR-Based Therapeutics Business (2018-2023) & (US$ Million)
Table 105. GE Healthcare Dharmacon Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global CRISPR-Based Therapeutics Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global CRISPR-Based Therapeutics Market Share by Type: 2022 VS 2033
Figure 3. Genome Editing Features
Figure 4. Genetic Engineering Features
Figure 5. gRNA Database/Gene Librar Features
Figure 6. CRISPR Plasmid Features
Figure 7. Human Stem Cells Features
Figure 8. Genetically Modified Organisms/Crops Features
Figure 9. Cell Line Engineering Features
Figure 10. Global CRISPR-Based Therapeutics Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 11. Global CRISPR-Based Therapeutics Market Share by Application: 2022 VS 2033
Figure 12. Biotechnology Companies Case Studies
Figure 13. Pharmaceutical Companies Case Studies
Figure 14. Academic Institutes Case Studies
Figure 15. Research and Development Institutes Case Studies
Figure 16. CRISPR-Based Therapeutics Report Years Considered
Figure 17. Global CRISPR-Based Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 18. Global CRISPR-Based Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 19. Global CRISPR-Based Therapeutics Market Share by Region: 2022 VS 2033
Figure 20. Global CRISPR-Based Therapeutics Market Share by Players in 2022
Figure 21. Global Top CRISPR-Based Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR-Based Therapeutics as of 2022)
Figure 22. The Top 10 and 5 Players Market Share by CRISPR-Based Therapeutics Revenue in 2022
Figure 23. North America CRISPR-Based Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. North America CRISPR-Based Therapeutics Market Share by Country (2018-2033)
Figure 25. United States CRISPR-Based Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Canada CRISPR-Based Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Europe CRISPR-Based Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Europe CRISPR-Based Therapeutics Market Share by Country (2018-2033)
Figure 29. Germany CRISPR-Based Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. France CRISPR-Based Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. U.K. CRISPR-Based Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Italy CRISPR-Based Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Russia CRISPR-Based Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Nordic Countries CRISPR-Based Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Asia-Pacific CRISPR-Based Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Asia-Pacific CRISPR-Based Therapeutics Market Share by Region (2018-2033)
Figure 37. China CRISPR-Based Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Japan CRISPR-Based Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. South Korea CRISPR-Based Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Southeast Asia CRISPR-Based Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. India CRISPR-Based Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Australia CRISPR-Based Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Latin America CRISPR-Based Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Latin America CRISPR-Based Therapeutics Market Share by Country (2018-2033)
Figure 45. Mexico CRISPR-Based Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Brazil CRISPR-Based Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Middle East & Africa CRISPR-Based Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Middle East & Africa CRISPR-Based Therapeutics Market Share by Country (2018-2033)
Figure 49. Turkey CRISPR-Based Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. Saudi Arabia CRISPR-Based Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Caribou Biosciences Revenue Growth Rate in CRISPR-Based Therapeutics Business (2018-2023)
Figure 52. Addgene Revenue Growth Rate in CRISPR-Based Therapeutics Business (2018-2023)
Figure 53. CRISPR THERAPEUTICS Revenue Growth Rate in CRISPR-Based Therapeutics Business (2018-2023)
Figure 54. Merck KGaA Revenue Growth Rate in CRISPR-Based Therapeutics Business (2018-2023)
Figure 55. Mirus Bio LLC Revenue Growth Rate in CRISPR-Based Therapeutics Business (2018-2023)
Figure 56. Editas Medicine Revenue Growth Rate in CRISPR-Based Therapeutics Business (2018-2023)
Figure 57. Takara Bio USA Revenue Growth Rate in CRISPR-Based Therapeutics Business (2018-2023)
Figure 58. Thermo Fisher Scientific Revenue Growth Rate in CRISPR-Based Therapeutics Business (2018-2023)
Figure 59. Horizon Discovery Group Revenue Growth Rate in CRISPR-Based Therapeutics Business (2018-2023)
Figure 60. Intellia Therapeutics Revenue Growth Rate in CRISPR-Based Therapeutics Business (2018-2023)
Figure 61. GE Healthcare Dharmacon Revenue Growth Rate in CRISPR-Based Therapeutics Business (2018-2023)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed